PHARMAGREEN BIOTECH INC. Net Change in Cash
PHARMAGREEN BIOTECH INC. reported Net Change in Cash of -$2.70 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-12-31 was $16.95K.
- PHARMAGREEN BIOTECH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-12-31 was -$14.83K.
- PHARMAGREEN BIOTECH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$17.28K, a 231.90% decline from fiscal 2021.
- PHARMAGREEN BIOTECH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $13.10K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$2.70K 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | -$630.00 10-Q · filed 2023-05-19 | |||
| 2022-12-31 | $16.95K 10-Q · filed 2023-02-14 | |||
| 2022-09-30 | -$17.28K 10-K · filed 2023-01-17 | |||
| 2022-06-30 | -$1.04K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$22.25K 10-Q · filed 2023-05-19 | |||
| 2021-12-31 | -$14.83K 10-Q · filed 2023-02-14 | |||
| 2021-09-30 | $13.10K 10-K · filed 2023-01-17 | |||
| 2021-06-30 | $7.02K 10-Q · filed 2022-08-17 | |||
| 2021-03-31 | $1.32K 10-Q · filed 2022-05-16 |